Filing Overview
This Form 8-K was filed by Jupiter Wellness, Inc., not BONK, INC. The report date was August 31, 2023, and it was signed on September 5, 2023. The filing covers the completion of an asset acquisition and related disclosures.
Business Context and Transaction
On July 10, 2023, Jupiter Wellness entered into an asset purchase agreement involving GBB Labs, Inc., GBB Drink Lab Inc., and related parties. On August 31, 2023, the Company completed the acquisition of certain GBB assets.
- Cash consideration: $200,000.
- Equity consideration: 5,000,000 common shares.
- The shares were issued in reliance on the Securities Act Section 4(a)(2) exemption and were not registered.
- The filing states that John Gulyas, now a Company director, and Jarrett A. Boon, now the Company’s Chief Operating Officer, each owned 33.33% of GBB.
Financial Metrics and Capitalization
The filing does not provide revenue, profit, cash flow, operating margins, debt, liquidity, or other period-specific financial metrics. It also does not provide the acquisition assets’ historical or projected financial results, valuation methodology, or pro forma impact.
The transaction increased the Company’s common shares outstanding by 5,000,000 shares, but the filing does not state the resulting share count or the transaction-date market value of the shares.
Material Changes Versus Prior Period
- Completion of the acquisition of certain GBB assets.
- Issuance of $200,000 in cash consideration and 5,000,000 common shares.
- Disclosure of management and board relationships with the acquired business and its owners.
- No comparable-period operating or financial data is included.
Outlook, Risks, and Unusual Items
The filing provides no formal financial guidance or operating outlook. The acquisition and unregistered share issuance may create dilution and integration, execution, and related-party transaction risks.
On September 5, 2023, outside counsel sent FSD Pharma Inc. a cease-and-desist letter concerning statements in an August 25, 2023 press release that Jupiter Wellness characterized as false and misleading, including use of the Company’s stock symbol without consent. The filing does not disclose the potential financial impact or resolution of this dispute.
Investor Verification Items
- Confirm the correct issuer: the supplied filing identifies Jupiter Wellness, Inc. and trading symbols JUPW and JUPWW, while the request metadata identifies BONK, INC.
- Review the complete asset purchase agreement to determine precisely which assets and liabilities were acquired.
- Verify the number of shares outstanding after issuance of the 5,000,000 consideration shares and the resulting ownership dilution.
- Assess the related-party implications of the GBB owners’ positions as Company director and Chief Operating Officer.
- Determine whether the acquired assets have generated material revenue or expenses and whether purchase accounting disclosures were subsequently provided.
- Monitor the dispute with FSD Pharma and any related litigation, regulatory, or financial consequences.